| Name | Title | Contact Details |
|---|
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the subject of more than 300 publications. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking.
Emerald Heights, sponsored by Emerald Communities, is a nonprofit 501(c)(3) senior housing and service organization that provides its residents programs to cultivate culture, vitality and independence. The community is a Type A Continuing Care Retirement Community (CCRC) that accommodates residents`changing needs throughout the aging process. Situated on 38 acres in the Education Hill area of Redmond, Wash., just 17 miles northeast of Seattle, Emerald Heights is an amenity-rich and resort-style senior living community, plus an assisted living facility and a Medicare-certified skilled nursing health center. The campus opened in 1992 to provide housing and service to people ages 55 and older in the aspects of independent, assisted living and skilled nursing.
Validation Technologies is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Surgical Weight Loss Centre is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Recent changes in Medicare coding requirements have caused hospitals to suffer from lost revenues, penalties and forfeiture of reimbursements due to inadequate documentation. Founder Dr. Jon Elion, who earlier created the highly successful Heartlab imaging software, tackled this problem with an expert team. The result was the company`s premiere product, ChartWise:CDI, which is the first-to-market Computer-Assisted Clinical Documentation Improvement (CACDI) software system designed to improve precision in quality clinical documentation to support revenue assurance. In February 2014 ChartWise launched an upgraded system, ChartWise 2.0—redefining CDI with powerful new features and an advance new user interface. The program is easy for medical professionals to understand and use, has a light IT footprint, and offers hospitals a way to mitigate risk, maximize reimbursement, and gain insight into their medical documentation improvement efforts. No other program is as robust, or addresses the clinical documentation challenges, the way ChartWise 2.0 does.